Skip to main content
. 2016 Dec 2;11(12):e0167720. doi: 10.1371/journal.pone.0167720

Table 1. Tumor MRI measurements before and after treatment.

Median (Interquartile range) D0 D1 D3 D7
Tv (mm3)
Treated (N = 14) 80.95 88.09 93.03 125.58
(8.09–120.52) (60.39–148.05) (53.52–156.50) (83.72–153.56)
Control (N = 8) 85.94 88.76 96.60 197.84
(41.85–193.19) (56.74–194.73) (64.25–216.03) (155.99–449.40)
ADC (×10−3 mm2/s)
Treated (N = 14) 0.66 0.69 0.72 0.74
(0.60–0.70) (0.63–0.70) (0.66–0.76) (0.67–0.81)
Control (N = 8) 0.61 0.60 0.60 0.62
(0.57–0.78) (0.58–0.77) (0.59–0.70) (0.59–0.70)
D* (×10−3 mm2/s)
Treated (N = 14) 2.44 1.43 1.25 1.25
(1.69–3.09) (1.30–1.80) (1.08–1.32) (1.12–1.50)
Control (N = 8) 2.15 1.95 1.99 1.85
(1.28–3.08) (1.25–2.71) (1.55–2.93) (1.23–2.82)
fp (%)
Treated (N = 14) 17.07 30.59 31.01 35.77
(13.59–23.99) (23.73–37.70) (23.42–39.90) (25.98–59.65)
Control (N = 8) 22.57 25.12 26.05 31.75
(12.94–37.54) (13.43–37.94) (18.16–39.08) (21.51–51.38)
D (×10−3 mm2/s)
Treated (N = 14) 0.48 0.39 0.35 0.31
(0.39–0.51) (0.27–0.44) (0.31–0.39) (0.09–0.40)
Control (N = 8) 0.48 0.50 0.50 0.45
(0.42–0.51) (0.42–0.54) (0.42–0.53) (0.36–0.49)